Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022:2:10550.
doi: 10.3389/adar.2022.10550. Epub 2022 Jul 14.

Role of Gut Microbiota in Cannabinoid-Mediated Suppression of Inflammation

Affiliations

Role of Gut Microbiota in Cannabinoid-Mediated Suppression of Inflammation

Kontham Kulangara Varsha et al. Adv Drug Alcohol Res. 2022.

Abstract

Cannabinoids and the endocannabinoid system have been well established to play a crucial role in the regulation of the immune response. Also, emerging data from numerous investigations unravel the imperative role of gut microbiota and their metabolites in the maintenance of immune homeostasis and gut barrier integrity. In this review, we concisely report the immunosuppressive mechanisms triggered by cannabinoids, and how they are closely associated with the alterations in the gut microbiome and metabolome following exposure to endogenous or exogenous cannabinoids. We discuss how cannabinoid-mediated induction of microbial secondary bile acids, short chain fatty acids, and indole metabolites, produced in the gut, can suppress inflammation even in distal organs. While clearly, more clinical studies are necessary to establish the cross talk between exo- or endocannabinoid system with the gut microbiome and the immune system, the current evidence opens a new avenue of cannabinoid-gut-microbiota-based therapeutics to regulate immunological disorders.

Keywords: cannabinoids; drug abuse; endocannabinoids; inflammation; microbiota.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Cannabinoids and gut microbiota. (A) Cannabinoid mediated microbiome modulation: endogenous or exogenous cannabinoids increase the beneficial bacteria which produce TJPs that improve gut barrier integrity and AMPs that eliminate pathogens. (B) Immunomodulatory mechanisms of microbial metabolites: microbiota generated secondary bile acids, SCFAs, and indole metabolites modulate various receptors leading to decreased pro-inflammatory cytokines and immune suppression. AhR, aryl hydrocarbon receptor; AMP, antimicrobial protein; CBR, cannabinoid receptor; CBs, cannabinoids; CNS, central nervous system; eCBs, endocannabinoids; FXR, farnesoid X receptor; GPR, G-protein-coupled receptors; HDACs, histone deacetylases; IFN, interferon; IL, interleukin; K, potassium; TJP, tight junction proteins; T-reg, regulatory T cell.

Similar articles

Cited by

References

    1. Boggs DL, Nguyen JD, Morgenson D, Taffe MA, Ranganathan M. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol. Neuropsychopharmacol. (2018) 43(1):142–54. 10.1038/npp.2017.209 - DOI - PMC - PubMed
    1. Pertwee RG. Cannabinoid Pharmacology: the First 66 Years. Br J Pharmacol (2006) 147(Suppl. 1):S163–71. 10.1038/sj.bjp.0706406 - DOI - PMC - PubMed
    1. Tham M, Yilmaz O, Alaverdashvili M, Kelly MEM, Denovan-Wright EM, Laprairie RB. Allosteric and Orthosteric Pharmacology of Cannabidiol and Cannabidiol-Dimethylheptyl at the Type 1 and Type 2 Cannabinoid Receptors. Br J Pharmacol (2019) 176(10):1455–69. 10.1111/bph.14440 - DOI - PMC - PubMed
    1. Munro S, Thomas KL, Abu-Shaar M. Molecular Characterization of a Peripheral Receptor for Cannabinoids. Nature (1993) 365(6441):61–5. 10.1038/365061a0 - DOI - PubMed
    1. Devane WA, Hanuš L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, et al. Isolation and Structure of a Brain Constituent that Binds to the Cannabinoid Receptor. Science (1992) 258(5090):1946–9. 10.1126/science.1470919 - DOI - PubMed

LinkOut - more resources